Public health genomics: Translating obesity genomics research into population health benefits

Obesity

Volumn 16, Issue SUPPL. 3, 2008, Pages

  Agurs Collins, Tanya ^a   Khoury, Muin J ^a,b   Simon Morton, Denise ^c   Olster, Deborah H ^d   Harris, Jennifer R ^d,e   Milner, John A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIORAL SCIENCE; ENVIRONMENT; EVIDENCE BASED MEDICINE; GENETIC SCREENING; GENETICS; GENOMICS; HEALTH BEHAVIOR; HUMAN; INFORMATION DISSEMINATION; METHODOLOGY; OBESITY; POPULATION GENETICS; PUBLIC HEALTH;

BEHAVIORAL SCIENCES; ENVIRONMENT; EVIDENCE-BASED MEDICINE; GENETIC RESEARCH; GENETIC SCREENING; GENETICS, POPULATION; GENOMICS; HEALTH BEHAVIOR; HUMANS; INFORMATION DISSEMINATION; OBESITY; PUBLIC HEALTH;

EID: 56849109001     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.517     Document Type: Article

References (72)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
2. Adams KF, Schatzkin A, Harris TB et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006;355:763-778.
3. Peeters A, Bonneux L, Nusselder WJ, De Laet C, Barendregt JJ. Adult obesity and the burden of disability throughout life. Obes Res 2004;12:1145-1151.
4. Wee CC, Phillips RS, Legedza AT et al. Health care expenditures associated with overweight and obesity among US adults: importance of age and race. Am J Public Health 2005;95:159-165.
5. Wolf AM. Economic outcomes of the obese patient. Obes Res 2002;10(Suppl 1):58S-62S.
6. Chung WK LR. Considerations regarding the genetics of obesity. Obesity 2008;16:S33-S39.
7. Rankinen T, Bouchard C. Genetics of food intake and eating behavior phenotypes in humans. Annu Rev Nutr 2006;26:413-434.
8. Wardle J, Carnell S, Haworth CM et al. Obesity-associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab 2008;93:3640-3643.
9. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert panel on the identification, evaluation, and treatment of overweight in Adults. Am J Clin Nutr 1998;68:899-917.
10. U.S. Preventive Services Task Force. Screening for obesity in adults: recommendations and rationale. Ann Intern Med 2003;139:930-932.
11. Katz DL, O'Connell M, Yeh MC et al. Public health strategies for preventing and controlling overweight and obesity in school and worksite settings: a report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep 2005;54:1-12.
12. Kumanyika SK, Obarzanek E, Stettler N et al. Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the expert panel on population and prevention science). Circulation 2008;118:428-464.
13. Morton NE. Into the post-HapMap era. Adv Genet 2008;60:727-742.
14. Abrahams E, Ginsburg GS, Silver M. The personalized medicine coalition: goals and strategies. Am J Pharmacogenomics 2005;5:345-355.
15. Glaser J, Henley DE, Downing G, Brinner KM, Health care workgroup of the American health information community. Advancing personalized health care through health information technology: an update from the American Health Information Community's Personalized Health Care Workgroup. J Am Med Inform Assoc 2008;15:391-396.
16. van't Veer LJ, Bernards R. Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 2008;452:564-570.
17. Haga SB, Khoury MJ, Burke W. Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nat Genet 2003;34:347-350.
18. Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle-will we get our wish? N Engl J Med 2008;358:105-107.
19. Burke W, Khoury MJ, Stewart A, Zimmern RL. The path from genomebased research to population health: development of an international public health genomics network. Genet Med 2006;8:451-458.
20. Khoury MJ, Davis R, Gwinn M, Lindegren ML, Yoon P. Do we need genomic research for the prevention of common diseases with environmental causes? Am J Epidemiol 2005;161:799-805.
21. Khoury MJ, Mensah GA. Genomics and the prevention and control of common chronic diseases: emerging priorities for public health action. Prev Chronic Dis 2005;2:A05.
22. Segal ME, Polansky M, Sankar P. Predictors of uptake of obesity genetic testing among affected adults. Hum Genet 2007;120:641-652.
23. Harvey-Berino J, Gold EC, West DS et al. Does genetic testing for obesity influence confidence in the ability to lose weight? A pilot investigation. J Am Diet Assoc 2001;101:1351-1353.
24. Frosch DL, Mello P, Lerman C. Behavioral consequences of testing for obesity risk. Cancer Epidemiol Biomarkers Prev 2005;14:1485-1489.
25. Rikke BA, Battaglia ME, Allison DB, Johnson TE. Murine weight loss exhibits significant genetic variation during dietary restriction. Physiol Genomics 2006;27:122-130.
26. Vazquez Roque MI, Camilleri M, Clark MM et al. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. Clin Gastroenterol Hepatol 2007;5:829-837.
27. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007;9:665-674.
28. Yu W, Wulf A, Yesupriya A, Clyne M, Khoury MJ, Gwinn M. HuGE Watch: tracking trends and patterns of published studies of genetic association and human genome epidemiology in near-real time. Eur J Hum Genet 2008;16:1155-1158.
29. Rankinen T, Zuberi A, Chagnon YC et al. The human obesity gene map: the 2005 update. Obesity 2006;14:529-644.
30. Centers for Disease Control and Prevention. National Center for Health Statistics. National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007. 〈http://www.cdc. gov/nchs/about/major/nhanes/ nhanes2007-2008/nhanes07-08.htm〉.
31. Fox CS, Heard-Costa N, Cupples LA, Dupuis J, Vasan RS, Atwood LD. Genome-wide association to body mass index and waist circumference: the Framingham heart study 100K project. BMC Med Genet 2007;8(Suppl 1):S18.
32. Khoury MJ, Gwinn M, Burke W, Bowen S, Zimmern R. Will genomics widen or help heal the schism between medicine and public health? Am J Prev Med 2007;33:310-317.
33. Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 2007;20:113-114.
34. Valli-Jaakola K, Lipsanen-Nyman M, Oksanen L et al. Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese Finnish children and adults. J Clin Endocrinol Metab 2004;89: 940-945.
35. Young EH, Wareham NJ, Farooqi S et al. The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals. Int J Obes (Lond) 2007;31:1437-1441.
36. Stutzmann F, Vatin V, Cauchi S et al. Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Hum Mol Genet 2007;16: 1837-1844.
37. Frayling TM, Timpson NJ, Weedon MN et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007;316:889-894.
38. Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 2007;39:724-726.
39. Scuteri A, Sanna S, Chen WM et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007;3:e115.
40. Cha SW, Choi SM, Kim KS et al. Replication of genetic effects of FTO polymorphisms on BMI in a Korean population. Obesity 2008;16:2187-2189.
41. Chang YC, Liu PH, Lee WJ et al. Common variation in the FTO gene confers risk of obesity and modulates body mass index in the Chinese population. Diabetes 2008;57:2245-2252.
42. Hotta K, Nakata Y, Matsuo T et al. Variations in the FTO gene are associated with severe obesity in the Japanese. J Hum Genet 2008;53:546-553.
43. Grant SF, Li M, Bradfield JP et al. Association analysis of the FTO gene with obesity in children of Caucasian and African ancestry reveals a common tagging SNP. PLoS ONE 2008;3:e1746.
44. Loos RJ, Bouchard C. FTO: the first gene contributing to common forms of human obesity. Obes Rev 2008;9:246-250.
45. Corella D, Lai CQ, Demissie S, et al. APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. J Mol Med 2007;85:119-128.
46. Grove ML, Morrison A, Folsom AR, Boerwinkle E, Hoelscher DM, Bray MS. Gene-environment interaction and the GNB3 gene in the Atherosclerosis Risk in Communities study. Int J Obes (Lond) 2007;31:919-926.
47. Ordovas JM, Tai ES. Why study gene-environment interactions? Curr Opin Lipidol 2008;19:158-167.
48. Tholin S, Rasmussen F, Tynelius P, Karlsson J. Genetic and environmental influences on eating behavior: the Swedish Young Male Twins Study. Am J Clin Nutr 2005;81:564-569.
49. Purcell S, Sham P. Variance components models for gene-environment interaction in quantitative trait locus linkage analysis. Twin Res 2002;5:572-576.
50. Purcell S. Variance components models for gene-environment interaction in twin analysis. Twin Res 2002;5:554-571.
51. Heitmann BL, Kaprio J, Harris JR, Rissanen A, Korkeila M, Koskenvuo M. Are genetic determinants of weight gain modified by leisure-time physical activity? A prospective study of Finnish twins. Am J Clin Nutr 1997;66:672-678.
52. Kallio P, Kolehmainen M, Laaksonen DE et al. Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study. Am J Clin Nutr 2007;85:1417-1427.
53. Ornish D, Magbanua MJ, Weidner G, et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A 2008;105:8369-8374.
54. Elliott RM, Johnson IT. Nutrigenomic approaches for obesity research. Obes Rev 2007;8(Suppl 1):77-81.
55. Bergmann MM, Bodzioch M, Bonet ML, Defoort C, Lietz G, Mathers JC. Bioethics in human nutrigenomics research: European Nutrigenomics Organisation workshop report. Br J Nutr 2006;95:1024-1027.
56. Svetkey LP, Moore TJ, Simons-Morton DG et al. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens 2001;19:1949-1956.
57. Yoon PW, Scheuner MT, Peterson-Oehlke KL, Gwinn M, Faucett A, Khoury MJ. Can family history be used as a tool for public health and preventive medicine? Genet Med 2002;4:304-310.
58. de Luis DA, Aller R, Izaola O, Sagrado MG, Conde R. Modulation of adipocytokines response and weight loss secondary to a hypocaloric diet in obese patients by -55CT polymorphism of UCP3 gene. Horm Metab Res 2008;40:214-218.
59. Geller G, Bernhardt BA, Holtzman NA. The media and public reaction to genetic research. JAMA 2002;287:773.
60. Mykitiuk R. Caveat emptor: direct-to-consumer supply and advertising of genetic testing. Clin Invest Med 2004;27:23-32.
61. Geransar R, Einsiedel E. Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware? Genet Test 2008; 12:13-23.
62. Bubela TM, Caulfield TA. Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers. CMAJ 2004;170:1399-1407.
63. Skinner CS, Schildkraut JM, Berry D et al. Pre-counseling education materials for BRCA testing: does tailoring make a difference? Genet Test 2002;6:93-105.
64. Simon R, Wang SJ. Use of genomic signatures in therapeutics development in oncology and other diseases. Pharmacogenomics J 2006;6:166-173.
65. El Sohemy A. Nutrigenetics. Forum Nutr 2007;60:25-30.
66. Madlensky L, McLaughlin JR, Carroll JC, Goel V, Frank JW. Risks and benefits of population-based genetic testing for Mendelian subsets of common diseases were examined using the example of colorectal cancer risk. J Clin Epidemiol 2005;58:934-941.
67. Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006;355:241-250.
68. Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. Genet Med 2007;9:819-825.
69. Thaul S, Lohr KN, Tranquada RE (eds). Health Services Research: Opportunities for an Expanding Field of Inquiry: An Interim Statement. Institute of Medicine, National Academy Press: Washington, DC, 1994.
70. Lipscomb J, Donaldson MS. Outcomes research at the National Cancer Institute: measuring, understanding, and improving the outcomes of cancer care. Clin Ther 2003;25:699-712.
71. Task Force on Developing Obesity Outcomes and Learning Standards (TOOLS). Proceedings of a symposium. Warrenton, Virginia, USA. June 11-13, 1999. Obes Res 2002;10(Suppl 1):1S-93S.
72. Eaton D. Gene-environment interactions. In: Hernandez LM (ed). Implications of Genomics for Public Health Workshop Summary. Institute of Medicine, National Academy Press: Washington, DC, 2005.